UnitedHealth Group Incorporated (NYSE:UNH) went up by 1.34% from its latest closing price compared to the recent 1-year high of $406.77. The company’s stock price has collected 4.27% of gains in the last five trading sessions. Press Release reported on 04/28/21 that UnitedHealthcare Enhances Integration of Medical and Specialty Benefits, Helping Improve Health Outcomes and Affordability
Is It Worth Investing in UnitedHealth Group Incorporated (NYSE :UNH) Right Now?
UnitedHealth Group Incorporated (NYSE:UNH) scored a price-to-earnings ratio above its average ratio, recording 23.38 x from its present earnings ratio. Plus, the 36-month beta value for UNH is at 0.78. Opinions of the stock are interesting as 20 analysts out of 25 who provided ratings for UnitedHealth Group Incorporated declared the stock was a “buy,” while 1 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $430.91, which is $19.57 above the current price. UNH currently public float of 943.06M and currently shorts hold a 0.70% ratio of that float. Today, the average trading volume of UNH was 3.27M shares.
UNH’s Market Performance
UNH stocks went up by 4.27% for the week, with a monthly jump of 11.12% and a quarterly performance of 21.44%, while its annual performance rate touched 43.05%. The volatility ratio for the week stands at 1.42% while the volatility levels for the past 30 days are set at 1.62% for UnitedHealth Group Incorporated. The simple moving average for the period of the last 20 days is 6.13% for UNH stocks with a simple moving average of 21.98% for the last 200 days.
Analysts’ Opinion of UNH
Many brokerage firms have already submitted their reports for UNH stocks, with Argus repeating the rating for UNH by listing it as a “Buy.” The predicted price for UNH in the upcoming period, according to Argus is $450 based on the research report published on April 21st of the current year 2021.
SVB Leerink gave a rating of “Outperform” to UNH, setting the target price at $360 in the report published on July 01st of the previous year.
UNH Trading at 12.08% from the 50-Day Moving Average
After a stumble in the market that brought UNH to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 1.12% of gains for the given period.
Volatility was left at 1.62%, however, over the last 30 days, the volatility rate increased by 1.42%, as shares surge +12.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.55% upper at present.
During the last 5 trading sessions, UNH rose by +4.27%, which changed the moving average for the period of 200-days by +34.19% in comparison to the 20-day moving average, which settled at $389.94. In addition, UnitedHealth Group Incorporated saw 17.30% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at UNH starting from ROOS THOMAS E, who sale 5,301 shares at the price of $394.66 back on Apr 27. After this action, ROOS THOMAS E now owns 35,104 shares of UnitedHealth Group Incorporated, valued at $2,092,093 using the latest closing price.
BURKE RICHARD T, the Director of UnitedHealth Group Incorporated, sale 12,500 shares at $394.59 during a trade that took place back on Apr 20, which means that BURKE RICHARD T is holding 1,301,500 shares at $4,932,375 based on the most recent closing price.
Stock Fundamentals for UNH
Current profitability levels for the company are sitting at:
- +8.71 for the present operating margin
The net margin for UnitedHealth Group Incorporated stands at +5.99. The total capital return value is set at 20.29, while invested capital returns managed to touch 15.27. Equity return is now at value 26.60, with 8.70 for asset returns.
Based on UnitedHealth Group Incorporated (UNH), the company’s capital structure generated 66.37 points at debt to equity in total, while total debt to capital is 39.89. Total debt to assets is 21.66, with long-term debt to equity ratio resting at 59.01. Finally, the long-term debt to capital ratio is 35.47.
When we switch over and look at the enterprise to sales, we see a ratio of 1.50, with the company’s debt to enterprise value settled at 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.74.